<DOC>
	<DOCNO>NCT00440401</DOCNO>
	<brief_summary>To demonstrate efficacy safety TachoSil® cardiovascular surgery</brief_summary>
	<brief_title>TachoSil® Versus Standard Haemostatic Treatment Haemorrhage Cardiovascular Surgery ( TC-023-IM )</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>All inclusion criterion must answer `` yes '' subject participate trial . At Screening : 1 . Has subject give informed consent accord local requirement trial related activity ? A trial related activity procedure would perform routine management subject . In trial screening first trial related activity . 2 . For female subject childbearing potential : Is pregnancy test screen negative ? 3 . Does female subject childbearing potential use adequate contraception ( contraceptive pill , contraceptive injection , contraceptive implant intrauterine device ) ? 4 . Is subject ≥ 18 year age ? 5 . Is follow plan : An elective surgery heart , ascend aorta arch , require cardiopulmonary bypass procedure ? Intra operative ( primary haemostatic treatment ) : 6 . Is bleed heart muscle , pericardium , major vessel vascular bed require supportive haemostatic treatment present ? 7 . Has area problematic haemorrhage ( target area ) identify ? ( please note must do randomisation ) . 8 . Is possible compress randomise treatment ( TachoSil® control fleece material ) 3 minute ? All exclusion criterion must answer `` '' subject participate trial . At Screening : 1 . Has subject participate trial investigational drug device within 30 day inclusion trial ? 2 . Does subject participate clinical trial concomitantly present trial ? 3 . Is subject undergoing emergency operation ? 4 . Has subject history allergic reaction application human fibrinogen , human thrombin and/or collagen origin ? 5 . Is subject suffer know coagulopathy ? 6 . Is subject currently participate subject previously participate TC023IM trial ? 7 . Is female subject pregnant breast feeding ? Intra operative ( primary haemostatic treatment ) : 8 . Has liquid fibrin sealant/glue TachoSil® apply ? 9 . Has follow occur : Disseminated intravascular coagulation ( DIC ) , i.e . micro vascular bleeding ?</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Surgical treatment haemorrhage</keyword>
</DOC>